Tell the FDA and State Leaders:
You will receive periodic updates about UltraViolet and related campaigns. You may unsubscribe at any time. Here's our
More and more healthcare providers are turning to telemedicine to ensure continued access to health care for patients while reducing the need for patients to travel to receive medical care, risking exposure to coronavirus. Both patients and doctors win in this scenario.
Medication abortion, when a pregnant person takes two types of pills that induce an abortion before 10-12 weeks, can also be conducted under the supervision of a physician via telemedicine. It is a safe and effective way to broaden access to abortion care for pregnant people.
And yet, 18 states force patients to travel to a clinician's office for medication abortion, and the Food and Drug Administration (FDA), despite the recommendations of medical experts including the American College of Obstetricians and Gynecologists, refuses to lift restrictions on mifepristone, one of the medications needed for medication abortion, that would enable providers to mail it to patients or prescribe it for pickup at a pharmacy.
These restrictions are nothing more than ideological, anti-woman excuses to restrict access to abortion. The impact of these restrictions falls disproportionately on women of color, indigenous people, and low-income folks. But if enough of us raise our voices and demand the FDA lift restrictions on mifepristone and that state lawmakers expand access to telemedicine for abortion, we can raise enough pressure to force the FDA and state lawmakers to expand access to abortion care and allow telemedicine! Will you sign the petition?